Back to Royal Bank of Canada Royal Bank of Canada

PRAXPRAX

Showing 8 of 11 quarters

Position history for Royal Bank of CanadaRoyal Bank of Canada's holdings in Praxis Precision Medicines, Inc.

Yes. Royal Bank of Canada holds 6,065 shares of PRAX (Praxis Precision Medicines), worth $2M, as of its Q2 2026 13F filing. It increased the position by 1,932 shares (+46.8%) from Q1 2026. Royal Bank of Canada has held PRAX since Q2 2024, across 9 quarterly 13F filings.

Current Value

$2M

Current Shares

6,065

Total Value Change

+$1.9M

Total Shares Change

+4,087

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
6,065
+46.8%
$2M0.0%$334.79
35
2026-Q1
Increased
4,133
+22.4%
$1.3M0.0%$322.19
31
2025-Q4
Decreased
3,378
-14.6%
$995,0000.0%$294.74
0
2025-Q3
Decreased
3,956
-82.5%
$209,0000.0%$53.00
0
2025-Q2
Increased
22,593
+208x
$950,0000.0%$42.05
40
2025-Q1
Decreased
108
-79.0%
$4,0000.0%$37.87
0
2024-Q4
Decreased
514
-74.0%
$39,0000.0%$76.96
0
2024-Q3
Increased
1,978
+21.9%
$113,0000.0%$57.54
18

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used